Direkt zum Inhalt
Merck

The preparation of 3,5-dihydroxy-4-isopropylstilbene nanoemulsion and in vitro release.

International journal of nanomedicine (2011-06-16)
Yue Zhang, Jungang Gao, Hetang Zheng, Ran Zhang, Yucui Han
ZUSAMMENFASSUNG

We have reported a novel procedure to prepare 3,5-dihydroxy-4-isopropylstilbene (DHPS) nanoemulsion, using a low-energy emulsification method. Based on the phase diagram, the optimum prescription of nanoemulsion preparation was screened. With polyoxyethylenated castor oil (EL-40) as the surfactant, ethanol as the co-surfactant, and isopropyl myristate (IPM) as the oil phase, the DHPS nanoemulsion was obtained with a transparent appearance, little viscosity, and spherically uniform distribution verified by transmission electron microscopy and laser scattering analyzer. The nanoemulsion was also determined by FT-Raman spectroscopy. The DHPS nanoemulsion demonstrated good stability and stable physical and chemical properties. The nanoemulsion dramatically improved the transdermal release of DHPS (from 8.02 μg · cm(-2) to 273.15 μg · cm(-2)) and could become a favorable new dosage form for DHPS.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Rizinusöl, ethoxyliert, pH range 6.0-8.0
Sigma-Aldrich
Rizinusöl, hydriert, ethoxyliert
Sigma-Aldrich
Isopropylmyristat, 98%
Sigma-Aldrich
Rizinusöl, ethoxyliert
Sigma-Aldrich
Isopropylmyristat, ≥98%
Sigma-Aldrich
Isopropylmyristat, ≥90% (GC)
Supelco
Isopropylmyristat, Pharmaceutical Secondary Standard; Certified Reference Material